Dr. John Anthony Giovannone Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 Bethlehem Pike, Erdenheim, PA 19038 Phone: 215-233-4485 |
Dr. Karli Marie Sartorio Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 Bethlehem Pike, Erdenheim, PA 19038 Phone: 215-233-4485 |
Dr. Jaclyn Michelle Shore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 Bethlehem Pike, Erdenheim, PA 19038 Phone: 215-233-4485 |
Jennifer Whelan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 920 Bethlehem Pike, Erdenheim, PA 19038 Phone: 215-233-4485 |
News Archive
RNA editing gives organisms a way to adapt the instructions that their DNA provides for making proteins. Few people would have described RNA editing as a simple process, but a new paper in Nature Communications demonstrates the process as more complex and difficult to predict than previously assumed. The study, done in living fruit flies, discovered two new mechanisms that govern editing in a key neurodevelopmental gene.
Biological siblings of people with gambling disorder also display markers of increased impulsivity and risk-taking, according to a new UBC psychology study. The findings, published today in Neuropsychopharmacology, suggest people with gambling disorder - a psychiatric term for serious gambling problems - may have pre-existing genetic vulnerabilities to the illness.
Stanford University officials on Tuesday plan to announce a new policy under which pharmaceutical and medical device companies no longer will have the ability to select continuing medical education courses that they seek to finance for physicians at the university's School of Medicine, the New York Times reports.
Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.
Adding to its market-leading portfolio of innovative medical technology for endovascular aortic repair (EVAR), Medtronic, Inc., announced today the CE (Conformité Européene) mark and international launch of the Captivia Delivery System for the Valiant Thoracic Stent Graft, a minimally invasive treatment for aneurysms and other lesions of the thoracic aorta.
› Verified 6 days ago